Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024)
Guided Therapeutics' (GTHP) quarterly Dividends Paid - Common came in at $54824.0 in Q2 2024, down 16.04% quarter-over-quarter from $65296.0 in Q1 2024.
Guided Therapeutics (GTHP) Dividends Paid - Common (2023 - 2024) Analysis & Trends
Guided Therapeutics has disclosed Dividends Paid - Common across 2 years of filings, most recently posting $54824.0 for Q2 2024.
- Dividends Paid - Common for Q2 2024 came in at $54824.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $120120.0 (up 83.96% YoY), and the FY2023 annual result was $65296.0, down 45.64% from the prior year.
- Dividends Paid - Common came in at $54824.0 for Q2 2024 at Guided Therapeutics, down from $65296.0 in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $65296.0 in Q1 2023 to a low of $54824.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.10 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 337.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 911.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 16.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 61.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 54,824.00 |
| Jun 30, 2024 | 54,824.00 |
| Mar 31, 2024 | 65,296.00 |
| Mar 31, 2024 | 65,296.00 |
| Mar 31, 2023 | 65,296.00 |
| Mar 31, 2023 | 65,296.00 |